$DIA Market GraphMargaret Lake Diamonds Inc. is a diamond exploring company listed on TSX-V with ticker symbol, currently sits at $0.18.
Daytrading
$IBOGF driving investors fanatical with profit$IBO over the years have maintained a solid and supple market cap, currently the company’s market capitalization is valued over $7.57M and is mounting effectively and the shares are actively being traded on OTC at $0.0376 per unit.
Universal Ibogaine Market SummaryUniversal Ibogaine Inc. is a Canadian Life science Company trading at OTC with ticker symbol $IBOGF currently sits at $0.0376 with volume around 10K+.
$IBOGF Stock EvaluationUniversal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of $7K in the last 3 months. The average volume of the company in the last 10 days is $5.02K with $190.74M share outstanding. The stock price when the market opened was $0.0397.
UI CEO’s rapturous to work with Blue Digital Media"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." As Blue Digital Media professional radar.
$IBO CO-Founder with wide ranging work-experienceDr. Sola, a co-founder of Universal Ibogaine and a member of its Board of Directors, has effectively administered over 3,700 ibogaine treatments, more than any other doctor in the world, at an independent clinic in Cancun, Mexico, where he is a partner.
$IBO’S CEO comments on the H.C Wainwright"H.C. Wainwright is a leader in the field and may be a significant strategic partner in our ongoing corporate finance roadmap," said Nick Karos, CEO of Universal Ibogaine. Another crucial step in raising awareness of our brand and service is the chance to share our story with this audience.
CEO highlights on the sheer extent of the research to reality ev"The significance of this occasion cannot be emphasized," said CEO Nick Karos. This is the first gathering of academic researchers, real-world technicians, and government policymakers of its sort. This event will raise awareness of ibogaine's great potential at the highest levels."
$HEM announcement related to the Stock Options GrantHemostemix Inc. announced that in accordance with its stock option plan, it has granted on February 28, 2022, subject to regulatory approval, a total of 1,494,269 stock options to purchase common shares of Hemostemix to directors, officers, employees and consultants of Hemostemix
$HEM- Market Opening ValueHemostemix Inc. is a publicly traded biotechnology company listed on TSX-V marked with an opening of $0.285.
$HEM volume increases Hemostemix Inc. is a biotechnology company listed on TSX-V with ticker symbol $HEM has shown growth in its volume. Today the volume is $8.62K.
Universal Ibogaine Inc. Market GraphUniversal Ibogaine Inc. holds a significant position over the OTC market with its greater difference between the lower and higher ranges of trading, which is $0.0258-$0.1143 in the last 52 weeks.
$IBOGF’s 52 week range dataUniversal Ibogaine Inc. is a life science company listed on OTC with the ticker symbol $IBOGF. In the last 52 weeks the range of the lower and upper price is $0.0258-$0.1143.
$IBO, Recognized as a powerful addiction interrupterOur mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.
While seeking to move Ibogaine through Clinical Trials in Canada, we are building a network of holistic recovery clinics and a state of the art treatment program centred around new treatment modalities.
Potential aptitude of NCP-01 by Hemostemix Neuropathic pain synNeuropathic pain syndromes can be treated with NCP-01 and its autologous stem cell technology, which can treat disorders of the central and peripheral nervous systems. Spinal cord injury, chronic brainstem injury, traumatic brain injury, and peripheral nerve injury are all examples of traumatic injuries and many more
$IBOGF stock evaluation and analysis$IBO stock ticker to Universal Ibogaine a company that provides ibogaine addiction treatment to patients tormented from opioid addiction in Canada is currently trading swiftly at $0.03734 with an evident hike.
$IBO and its revolutionary addiction treatment protocolUI is developing an advanced holistic addiction treatment protocol, at its Kelburn Recovery Centre, that when combined with the planned ibogaine detox methodology is expected to transform the way we treat addiction and dramatically promote the welfare of families affected by addiction.
$IBO with an brilliant profit deliveranceExcellence and IBO always go hand in hand when it comes to proving its potential in the market and leaving competitors way behind the bar. The shares are trading live at $0.05 with a significant spike
Universal Ibogaine in the Virtual Growth ConferenceUniversal Ibogaine Inc. is going to participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest.
$IBOGF higher day rangeUniversal Ibogaine Inc. a life science company listed on OTC with the ticker symbol $IBOGF has been seen with a higher day range difference. The day range is $0.0367-$0.0385.
Universal Ibogaine market cap growing relentlessly$IBOGF has established a remarkable market cap as compared to its fellow penny stocks in the market, currently the market cap is valued at $9.07 Million which has increased twice within a week.
$IBO soon to commission ultra- modern addiction treatment centreAt the Kelburn Clinic, UI is developing a cutting-edge holistic addiction treatment protocol that, when combined with the anticipated ibogaine detox programme, will transform the way we treat addiction and dramatically enhance the lives of individuals and families plagued by addiction.
$IBOGF mounting rapidly on OTC with a huge 178% bump$IBOGF is trading swiftly in the market and observing a plenty of investor activities, the shares are trading live on OTC at $0.095 with an amazing 178% profit on value per share.
